Jay Stout
Directeur Technique/Scientifique/R&D chez IMMUNOVANT, INC.
Fortune : 4 M $ au 31/05/2024
Postes actifs de Jay Stout
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 | - |
Historique de carrière de Jay Stout
Anciens postes connus de Jay Stout
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | 25/04/2017 | - |
Formation de Jay Stout
| The University of Nebraska-Lincoln | Doctorate Degree |
| University of Iowa | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
